More than 17,000 individuals with cancer died from their malignancy within a year of their diagnosis during the COVID-19 pandemic than expected based on previous trends.
An evaluation of 1-year survival data showed significant mortality increases for multiple malignancies, including lung, colorectal, pancreatic and prostate cancer.
“Our goal is to save lives, to reduce unnecessary loss of life,” Todd Burus, PhD, assistant professor of internal medicine at University of Kentucky College of Medicine, told Healio. “During the COVID-19 pandemic, [health care] really focused on reducing unnecessary